Latest Breaking News On - Thomas scheeren - Page 1 : comparemela.com

Edwards software may reduce hypotension severity, study says

Edwards Lifesciences today announced study results that support the use of its Acumen HPI software.

Thomas scheerenEdwards lifesciences

Edwards Lifesciences: Improving Patient Safety and Outcomes: EU-HYPROTECT Registry Demonstrates Reduced Time in Hypotension During Surgery Using Acumen HPI Software

Edwards Lifesciences: Improving Patient Safety and Outcomes: EU-HYPROTECT Registry Demonstrates Reduced Time in Hypotension During Surgery Using Acumen HPI Software
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomEdwards lifesciencesJulie tracolThomas scheerenAnesth analgEdwards lifesciences corporationAssociation of intraoperative hypotensionAcumen hypotension prediction indexBusiness wireBernd saugelSenior director medical affairsBritish journalHypotension prediction indexPredict postoperative mortalityEnglj medIntraoperative hypotension

Study says Edwards software could help reduce hypotension

Edwards Lifesciences (NYSE:EW) today announced results from a registry demonstrating the effect of software on reducing hypotension.

United kingdomThomas scheerenEdwards lifesciencesEdwards acumen

Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference

Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference News provided by Share this article Share this article IRVINE, Calif., Dec. 10, 2020 /PRNewswire/ Edwards Lifesciences Corporation (NYSE: EW) will discuss the company s strategy for longer-term growth, provide an update on its technology pipeline and share its financial guidance today during its annual investor conference. Highlights Presenting long-term strategic initiatives and growth outlook Projecting 2021 global sales of $4.9-5.3 billion; underlying growth in the mid-teens Projecting 2021 TAVR sales of $3.2-3.6 billion; underlying growth 15-20% Estimating 2021 adjusted earnings per share $2.00-2.20 Putting patients first has never been more important than it is in 2020, and I am humbled by the agility, resourcefulness and passion of our partners and employees in maintaining their important work on behalf of patients during this particularly difficult time, said Michael A. Mussallem, chai

New yorkUnited statesColumbia universityUniversity hospitalNeil famMichaela mussallemJean luc lemercierScott ullemTodd brintonLos angelesSuzanne baronBassem chehabHuimin wangMichael sanderThomas scheerenKatie szyman